Zhang H - Search Results

1

Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.

Zhuang ZX, Zhu H, Wang J, Zhu MG, Wang H, Pu WY, Bian HH, Chen L, Zhang H. Zhuang ZX, et al. Among authors: zhang h. Acta Pharmacol Sin. 2013 Apr;34(4):570-80. doi: 10.1038/aps.2012.169. Epub 2013 Feb 11. Acta Pharmacol Sin. 2013. PMID: 23396375 Free PMC article. Clinical Trial.

2

Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.

Wang H, Feng F, Wang XP, Wang RS, Wu Y, Zhu MG, Zhang H, Zhuang ZX. Wang H, et al. Among authors: zhang h. Mol Med Rep. 2016 Feb;13(2):1077-82. doi: 10.3892/mmr.2015.4654. Epub 2015 Dec 7. Mol Med Rep. 2016. PMID: 26647961 Free PMC article.

3

Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α.

Zhu H, Luo SF, Wang J, Li X, Wang H, Pu WY, Zhang H, Zhuang ZX. Zhu H, et al. Among authors: zhang h. Chin Med J (Engl). 2012 Mar;125(6):1095-103. Chin Med J (Engl). 2012. PMID: 22613537

4

Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma.

Li C, Wang J, Zhang H, Zhu M, Chen F, Hu Y, Liu H, Zhu H. Li C, et al. Among authors: zhang h. Oncotarget. 2014 Sep 30;5(18):8429-41. doi: 10.18632/oncotarget.2316. Oncotarget. 2014. PMID: 25238261 Free PMC article.

5

PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway.

Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, Lin K, Zhou X, Tao M, Li C, Zhu H. Yang Z, et al. Among authors: zhang h. Sci Rep. 2016 Feb 26;6:22090. doi: 10.1038/srep22090. Sci Rep. 2016. PMID: 26915315 Free PMC article.

6

The novel mTORC1/2 dual inhibitor INK128 enhances radiosensitivity of breast cancer cell line MCF-7.

Liu ZG, Tang J, Chen Z, Zhang H, Wang H, Yang J, Zhang H. Liu ZG, et al. Among authors: zhang h. Int J Oncol. 2016 Sep;49(3):1039-45. doi: 10.3892/ijo.2016.3604. Epub 2016 Jul 5. Int J Oncol. 2016. PMID: 27574017

7

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis.

Wang H, Yu Y, Jiang Z, Cao WM, Wang Z, Dou J, Zhao Y, Cui Y, Zhang H. Wang H, et al. Among authors: zhang h. Sci Rep. 2016 May 24;6:26456. doi: 10.1038/srep26456. Sci Rep. 2016. PMID: 27217076 Free PMC article.

8

PRDX6 Protects ARPE-19 Cells from Oxidative Damage via PI3K/AKT Signaling.

Zha X, Wu G, Zhao X, Zhou L, Zhang H, Li J, Ma L, Zhang Y. Zha X, et al. Among authors: zhang h, zhang y. Cell Physiol Biochem. 2015;36(6):2217-28. doi: 10.1159/000430186. Epub 2015 Jul 24. Cell Physiol Biochem. 2015. PMID: 26279427 Free article.

9

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells.

Wang Z, Zhang H, Shi M, Yu Y, Wang H, Cao WM, Zhao Y, Zhang H. Wang Z, et al. Among authors: zhang h. Sci Rep. 2016 Sep 7;6:32737. doi: 10.1038/srep32737. Sci Rep. 2016. PMID: 27599572 Free PMC article.

10

PRDX6 regulates the H2O2 and blue light-induced APRE-19 cell apoptosis via down-regulating and interacting with RARA.

Zha X, Wu G, Zhang H, Yang Y, Zhang Y, Ma L. Zha X, et al. Among authors: zhang h, zhang y. Anim Cells Syst (Seoul). 2019 Apr 11;23(4):241-245. doi: 10.1080/19768354.2019.1592021. eCollection 2019. Anim Cells Syst (Seoul). 2019. PMID: 31489244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130,230 results

Search Page

Filters